As of Jun 22, 2026, the USNA stock has a PE ratio of 39.38. The calculation is based on the latest EPS of $0.48 and the stock price of $18.9 per share. An increase of 33% has been observed in the PE ratio compared to its average of 29.6 of the last four quarters.
The mean historical PE ratio of Usana Health Sciences over the last ten years is 18.74. The current 39.38 P/E ratio is 110% higher than the historical average. Looking back at the last ten years, USNA's PE ratio peaked in the Apr 2026 quarter at 35.21, with a price of $16.9 and an EPS of $0.48. The Mar 2020 quarter marked the lowest point at 12.76, with a price of $59.35 and an EPS of $4.65.
Maximum annual increase: 106.66% in 2026
Maximum annual decrease: -37.75% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2026 | 33.52 | 106.66% | $19.44 | $0.58 |
| 2024 | 16.22 | 0.19% | $35.69 | $2.2 |
| 2023 | 16.19 | 9.54% | $53.6 | $3.31 |
| 2022 | 14.78 | -15.59% | $53.2 | $3.6 |
| 2022 | 17.51 | 33.77% | $101.2 | $5.78 |
| 2021 | 13.09 | -27.36% | $77.1 | $5.89 |
| 2019 | 18.02 | -17.87% | $80 | $4.44 |
| 2018 | 21.94 | -23.85% | $114.96 | $5.24 |
| 2017 | 28.81 | 94.93% | $74.05 | $2.57 |
| 2016 | 14.78 | -13.92% | $61.2 | $4.14 |
| 2016 | 17.17 | -2.61% | $63.88 | $3.72 |
| 2015 | 17.63 | 30.69% | $51.14 | $2.9 |
| 2013 | 13.49 | 95.51% | $38.86 | $2.88 |
| 2012 | 6.9 | -25% | $15.8 | $2.29 |
| 2011 | 9.2 | -37.75% | $15.19 | $1.65 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Apr 2026 | 35.21 | 5.04% | $16.9 | $0.48 |
| Jan 2026 | 33.52 | 3.39% | $19.44 | $0.58 |
| Sep 2025 | 32.42 | 87.51% | $28.53 | $0.88 |
| Jun 2025 | 17.29 | 13.9% | $31.13 | $1.8 |
| Mar 2025 | 15.18 | -6.41% | $27.78 | $1.83 |
| Dec 2024 | 16.22 | 21.5% | $35.69 | $2.2 |
| Sep 2024 | 13.35 | -15.29% | $37.92 | $2.84 |
| Jun 2024 | 15.76 | 4.3% | $45.24 | $2.87 |
| Mar 2024 | 15.11 | -6.67% | $48.5 | $3.21 |
| Dec 2023 | 16.19 | -14.65% | $53.6 | $3.31 |
| Sep 2023 | 18.97 | -1.3% | $58.61 | $3.09 |
| Jul 2023 | 19.22 | 3.61% | $63.04 | $3.28 |
| Apr 2023 | 18.55 | 25.51% | $62.9 | $3.39 |
| Dec 2022 | 14.78 | 5.5% | $53.2 | $3.6 |
| Oct 2022 | 14.01 | -14.26% | $56.05 | $4 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of USNA is higher than its 3, 5 and 10-year averages.
With a price to earnings (P/E) of 39.38, USNA ranks higher than the Consumer Defensive sector, the industry and its peers average. In comparison with the Consumer Defensive sector average of 21.13, Usana Health Sciences's price to earnings (P/E) is 86% higher.
USNA's PE ratio stands higher than its peer stocks IPAR and HLF. Usana Health Sciences is currently trading at a higher PE ratio (39.38) than its peers average of 11.63.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NUS Nu Skin Enterprises Inc | 4.57 | $250.52M |
| HLF Herbalife Nutrition Ltd | 5.26 | $1.27B |
| NATR Natures Sunshine Products Inc | 18.73 | $365.59M |
| IPAR Inter Parfums Inc | 18.83 | $3.18B |
| USNA Usana Health Sciences Inc | 40 | $354.49M |
| MTEX Mannatech Inc | N/A | $10.36M |
The price to earnings ratio for USNA stock as of Jun 22, 2026, stands at 39.38.
The average PE ratio for USNA stock over the past 3 years is 20.7.
The average PE ratio for USNA stock over the past 5 years is 18.68.
The current PE of 39.38 represents the highest historical value in the last ten years.
USNA's current price to earnings ratio is 110% above its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Usana Health Sciences's share price is $18.9. The company's earnings per share for the trailing twelve months (TTM) ending Apr 2026 is $0.48. Therefore, Usana Health Sciences's PE ratio for today is 39.38. PE RATIO(39.38) = STOCK PRICE($18.9) / TTM EPS($0.48)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.